StressModex for Post-Traumatic Neck Pain
StressModex
Early Stratified Physiotherapy Combined With Stress Inoculation Training for Individuals at Risk of Persistent Post-Traumatic Neck Pain: A Randomized Pilot Trial.
1 other identifier
interventional
30
1 country
3
Brief Summary
Post-traumatic neck pain is a common consequence of traffic-related and other accidental injuries. While many individuals recover, a subgroup develops persistent pain, disability, and psychological distress. Building on previous adaptation and feasibility work, this randomised pilot trial will assess the feasibility of conducting a future definitive randomised controlled trial comparing StressModex plus treatment as usual (TAU) with TAU alone in individuals at risk of persistent post-traumatic neck pain. The primary feasibility objectives are to assess recruitment using a revised multi-source recruitment strategy and participant retention and remote outcome data collection. Secondary feasibility objectives are to assess the feasibility and acceptability of randomisation, characterise TAU and concurrent healthcare use, and estimate parameters relevant to the sample size calculation for a future definitive RCT. Intervention fidelity, adherence, acceptability, safety, and practical aspects of intervention delivery will additionally be monitored. The pilot trial is not designed or powered to evaluate the effectiveness of StressModex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 2, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
September 17, 2026
August 1, 2026
1.3 years
September 2, 2026
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Recruitment rate
Recruitment rate will be assessed as the number of participants randomised per month during the active recruitment period. Recruitment will be evaluated against prespecified progression criteria: ≥5 participants per month (go), 3 to \<5 participants per month (amend), and \<3 participants per month (stop/reconsider).
Throughout the active recruitment period, up to 10 months
Participant retention at 6-month follow-up
Retention will be assessed as the proportion of randomised participants retained at the 6-month follow-up. Retention will be evaluated against prespecified progression criteria: ≥75% retention (go), 50 to \<75% retention (amend), and \<50% retention (stop/reconsider).
6 months after randomisation
Secondary Outcomes (10)
Participant retention at 6-week and 3-month follow-up
6 weeks and 3 months after randomisation
Completeness of remotely collected outcome data
Baseline, 6 weeks, 3 months, and 6 months
Acceptance of randomisation
At enrolment, prior to randomisation
Withdrawal following treatment allocation
From randomisation to 6-month follow-up
Treatment as usual and concurrent healthcare use
Baseline, 6 weeks, 3 months, and 6 months
- +5 more secondary outcomes
Other Outcomes (21)
Pain intensity
Baseline, 6 weeks, 3 months, and 6 months
Post-traumatic stress symptoms
Baseline, 6 weeks, 3 months, and 6 months
Hyperarousal symptoms
Baseline, 6 weeks, 3 months, and 6 months
- +18 more other outcomes
Study Arms (2)
StressModex plus Treatment as Usual
EXPERIMENTALParticipants allocated to this arm will receive StressModex in addition to treatment as usual (TAU). StressModex comprises 10 physiotherapy sessions delivered over six weeks and combines individually tailored, guideline-based physiotherapy with Stress Inoculation Training (SIT). SIT is integrated into six of the 10 sessions. Participants remain free to seek additional healthcare according to usual Danish practice throughout the study period.
Treatment as Usual
NO INTERVENTIONParticipants allocated to this arm will not receive the StressModex intervention. They will continue with treatment as usual and remain free to seek healthcare according to usual Danish practice, including consultation with their general practitioner and treatment from other healthcare providers as considered necessary.
Interventions
StressModex is a physiotherapist-delivered intervention combining guideline-based exercise therapy with stress inoculation training. Participants receive 10 treatment sessions over six weeks. Exercise components target neck mobility, strength, endurance, and sensorimotor function. Stress inoculation training components are integrated into six sessions and focus on stress education, relaxation strategies, coping skills, and self-management of stress-related symptoms following trauma.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Post-traumatic neck pain with symptom duration of less than 6 months
- Moderate neck-related disability, defined as Neck Disability Index (NDI) score ≥32%
- Hyperarousal symptoms defined as a score of ≥3 on the hyperarousal subscale of the Posttraumatic Diagnostic Scale (PDS)
- Able to read, understand, and communicate in Danish
You may not qualify if:
- Known or suspected spinal pathology, including confirmed fracture or vertebral displacement related to the injury
- Severe pre-existing pain condition judged to interfere with participation in the intervention, such as disc herniation, fractures, or recent major surgery
- Known severe psychiatric disorder, including schizophrenia spectrum disorder or bipolar disorder, if the condition is currently considered unstable, insufficiently treated, or likely to affect the participant's ability to provide informed consent or participate meaningfully in the study
- Known active misuse of alcohol, illicit drugs, anxiolytic medication, or opioids
- Progressive neurological or rheumatological disorder causing substantial functional limitations and expected to interfere with participation in the intervention or assessment of treatment effect
- Severe traumatic brain injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Slagelse Hospitalcollaborator
- The Research and Implementation Unit PROgrez, Region Zealand,Denmarkcollaborator
- University College South Denmarkcollaborator
- Hospital of Southern Jutlandcollaborator
- Specialized Hospital for Polio and Accident Victims, Rødovre, Denmarkcollaborator
- Spine Centre of Southern Denmarkcollaborator
Study Sites (3)
Hospital of Southern Jutland
Aabenraa, Denmark
Specialized Hospital for Polio and Accident Victims
Rødovre Municipality, Denmark
Central and West Zealand Hospital
Slagelse, Denmark
Related Publications (5)
Willaert W, Leysen L, Lenoir D, Meeus M, Cagnie B, Nijs J, Sterling M, Coppieters I. Combining Stress Management With Pain Neuroscience Education and Exercise Therapy in People With Whiplash-Associated Disorders: A Clinical Perspective. Phys Ther. 2021 Jul 1;101(7):pzab105. doi: 10.1093/ptj/pzab105.
PMID: 33764474BACKGROUNDCoronado RA, Brintz CE, McKernan LC, Master H, Motzny N, Silva FM, Goyal PM, Wegener ST, Archer KR. Psychologically informed physical therapy for musculoskeletal pain: current approaches, implications, and future directions from recent randomized trials. Pain Rep. 2020 Sep 23;5(5):e847. doi: 10.1097/PR9.0000000000000847. eCollection 2020 Sep-Oct.
PMID: 33490842BACKGROUNDRitchie C, Hendrikz J, Jull G, Elliott J, Sterling M. External validation of a clinical prediction rule to predict full recovery and ongoing moderate/severe disability following acute whiplash injury. J Orthop Sports Phys Ther. 2015 Apr;45(4):242-50. doi: 10.2519/jospt.2015.5642.
PMID: 25827122BACKGROUNDRitchie C, Hendrikz J, Kenardy J, Sterling M. Derivation of a clinical prediction rule to identify both chronic moderate/severe disability and full recovery following whiplash injury. Pain. 2013 Oct;154(10):2198-2206. doi: 10.1016/j.pain.2013.07.001. Epub 2013 Jul 4.
PMID: 23831865BACKGROUNDSterling M, Smeets R, Keijzers G, Warren J, Kenardy J. Physiotherapist-delivered stress inoculation training integrated with exercise versus physiotherapy exercise alone for acute whiplash-associated disorder (StressModex): a randomised controlled trial of a combined psychological/physical intervention. Br J Sports Med. 2019 Oct;53(19):1240-1247. doi: 10.1136/bjsports-2018-100139. Epub 2019 Jan 19.
PMID: 30661011BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
René B Jørgensen, Msc
University of Southern Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, participants and treating physiotherapists cannot be blinded to treatment allocation. Statistical analyses will be conducted by a statistician blinded to group allocation.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2026
First Posted
September 17, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
September 17, 2026
Record last verified: 2026-08